MktsMarkets

Mereo BioPharma Group plc
NASDAQ: MREOKey statistics
MREO News
Stories mentioning MREO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 500.00 | 0.00 | 0.00 | 0.00 | |||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | ||||||
| Operating Expenses | ||||||||
| Research & Development | 4,747 | 4,193 | 4,270 | 5,373 | 3,930 | 8,820 | 3,170 | 4,946 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (8,766) | (8,391) | (10,015) | (10,499) | (11,202) | (15,277) | (9,373) | (12,814) |
| Interest Income | 327.00 | 421.00 | 504.00 | 589.00 | 659.00 | 882.00 | 983.00 | 559.00 |
| Interest Expense | 20.00 | 23.00 | 28.00 | 24.00 | 180.00 | 376.00 | 353.00 | 331.00 |
| Other Expense | 0.00 | 0.00 | 0.00 | |||||
| Pretax Income | (6,719) | (7,351) | (7,024) | (14,616) | (12,887) | (7,046) | (15,001) | (12,255) |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | (6,719) | (7,351) | (7,024) | (14,616) | (12,887) | (7,046) | (15,001) | (12,255) |
| Earnings Per Share (Basic) | (0.01) | (0.01) | (0.01) | (0.02) | (0.02) | (0.01) | (0.02) | (0.02) |
| Earnings Per Share (Diluted) | (0.01) | (0.01) | (0.01) | (0.02) | (0.02) | (0.01) | (0.02) | (0.02) |
| Weighted Average Shares Outstanding (Basic) | 801,806 | 797,120 | 799,947 | 799,435 | 784,279 | 739,624 | 770,147 | 770,147 |
| Weighted Average Shares Outstanding (Diluted) | 801,806 | 797,120 | 799,947 | 799,435 | 784,279 | 739,624 | 770,147 | 770,147 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MREO
Mereo BioPharma Group plc (NASDAQ: MREO) is a stock listed on the Nasdaq Stock Market under the ticker symbol MREO. It last traded at $0.3000 (Nov 5, 2026, 9:53 AM ET), down 1.0% on the day. That gives Mereo BioPharma a market capitalisation of $46.4M.
Over the past 52 weeks MREO has traded between $0.2000 and $2.37.
For the quarter ended Mar 31, 2026 it reported a net loss of $6.7M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | — | -$6.7M | — |
| Dec 31, 2025 | — | -$7.4M | — |
| Sep 30, 2025 | $0 | -$7.0M | — |
| Jun 30, 2025 | $500.0K | -$14.6M | -2923.2% |
From Mereo BioPharma’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…